Troyen Brennan
Director/Board Member chez LUMIRADX LIMITED
Fortune : - $ au 31/12/2023
Profil
Troyen A.
Brennan is currently a Director at LumiraDx Ltd.
(Cayman Islands), LumiraDx UK Ltd., and LumiraDX Ltd.
He is also a Trustee at Dartmouth-Hitchcock Medical Center and a Member at the Institute of Medicine of The National Academies of Science.
Previously, he served as President & Chief Executive Officer at The Brigham & Women's Hospital, Inc. and Brigham & Women’s Physicians Organization, Inc. He was also the Chief Medical Officer & Executive Vice President at Aetna, Inc. and CVS Health Corp.
Dr. Brennan's education includes an undergraduate degree from Southern Methodist University, a graduate degree from the University of Oxford, and graduate and doctorate degrees from Yale School of Medicine and Yale Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LUMIRADX LIMITED
-.--% | 31/12/2022 | 0 ( -.--% ) | - $ | 31/12/2023 |
Postes actifs de Troyen Brennan
| Sociétés | Poste | Début |
|---|---|---|
| LUMIRADX LIMITED | Director/Board Member | 01/11/2016 |
LumiraDx UK Ltd.
 LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | Director/Board Member | - |
LumiraDx Ltd. (Cayman Islands)
 LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Director/Board Member | 01/11/2016 |
Dartmouth-Hitchcock Medical Center
 Dartmouth-Hitchcock Medical Center Hospital/Nursing ManagementHealth Services Dartmouth-Hitchcock Medical Center operates a general medical hospital. It is a nonprofit academic health system. The firm health care professionals offer clinical, education, research, nursing, specialty referrals and resource services. The company was founded in 1893 and is headquartered in Lebanon, NH. | Director/Board Member | - |
Dartmouth-Hitchcock
 Dartmouth-Hitchcock Miscellaneous Commercial ServicesCommercial Services Dartmouth-Hitchcock operates as non-profitable health organization. It offers cancer, cardiology and heart surgery, gastroenterology, geriatrics, neurology and neurosurgery, gynecology, nephrology, orthopedics, pulmonology, rheumatology and urology care services. The company was founded in 1893 and is headquartered in Lebanon, NH. | Director/Board Member | 20/03/2015 |
| Harvard T.H. Chan School of Public Health | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
| Institute of Medicine of The National Academies of Science | Corporate Officer/Principal | - |
Anciens postes connus de Troyen Brennan
| Sociétés | Poste | Fin |
|---|---|---|
| CVS HEALTH CORPORATION | Chief Tech/Sci/R&D Officer | 01/04/2022 |
| ░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Troyen Brennan
| Southern Methodist University | Undergraduate Degree |
| University of Oxford | Graduate Degree |
| Yale Law School | Graduate Degree |
| Yale School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CVS HEALTH CORPORATION | Retail Trade |
| DECIBEL THERAPEUTICS, INC. | Health Technology |
| LUMIRADX LIMITED | Health Technology |
| Entreprise privées | 9 |
|---|---|
Aetna, Inc.
 Aetna, Inc. Managed Health CareHealth Services Aetna, Inc. engages in the provision of traditional, voluntary, and consumer-directed health insurance products and related services. It offers benefits, products and services to individuals, employers, healthcare professionals, and producers. The company was founded by Eliphalet Adams Bulkeley in 1853 and is headquartered in Hartford, CT. | Health Services |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
Dartmouth-Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center Hospital/Nursing ManagementHealth Services Dartmouth-Hitchcock Medical Center operates a general medical hospital. It is a nonprofit academic health system. The firm health care professionals offer clinical, education, research, nursing, specialty referrals and resource services. The company was founded in 1893 and is headquartered in Lebanon, NH. | Health Services |
Generation Health, Inc.
 Generation Health, Inc. Medical/Nursing ServicesHealth Services Generation Health, Inc. provides health management services focuses on genetic testing benefit management. The company was founded by Graham Gardner, J. Christian Kryder, Ricahrad K. Schatzberg, Per G. H. Lofberg, and David M. Margulies on September 23, 2008 and is headquartered in Upper Saddle River, NJ. | Health Services |
| Brigham & Women’s Physicians Organization, Inc. | Commercial Services |
Dartmouth-Hitchcock
Dartmouth-Hitchcock Miscellaneous Commercial ServicesCommercial Services Dartmouth-Hitchcock operates as non-profitable health organization. It offers cancer, cardiology and heart surgery, gastroenterology, geriatrics, neurology and neurosurgery, gynecology, nephrology, orthopedics, pulmonology, rheumatology and urology care services. The company was founded in 1893 and is headquartered in Lebanon, NH. | Commercial Services |
LumiraDx Ltd. (Cayman Islands)
LumiraDx Ltd. (Cayman Islands) BiotechnologyHealth Technology LumiraDx UK Ltd. is a POC diagnostic company. The firm focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. It develops and launches platform, which is an integrated system comprised of a small, versatile Instrument, precise, low-cost microfluidic test strips, and seamless, secure digital connectivity. The company was founded by Ronald Zwanziger, Jerry McAleer and David Scott on September 5, 2014 and is headquartered in George Town, Cayman Islands. | Health Technology |
LumiraDx UK Ltd.
LumiraDx UK Ltd. Medical SpecialtiesHealth Technology Part of LumiraDX Ltd., LumiraDx UK Ltd. is a healthcare company based in London, UK. LumiraDx was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million. The British company offers innovative diagnostic solutions for community-based healthcare, including point-of-care testing, digital connectivity, and diagnostic-led therapy solutions for chronic conditions. LumiraDx Fast Lab Solutions is a dedicated business unit that supports high-complexity laboratory testing. The private company's bespoke, high-throughput manufacturing line produces precise microfluidic test strips for their diagnostic platform, which delivers results comparable to standard laboratory reference methods. The company was founded in 2014 by Ronald Zwanziger and Jerome Francis McAleer, with Zwanziger serving as CEO since then. | Health Technology |
| Institute of Medicine of The National Academies of Science |
